🇺🇸 FDA
Patent

US 9169354

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

granted A61KA61K47/59

Quick answer

US patent 9169354 (Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K47/59